SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029292
Filing Date
2018-11-13
Accepted
2018-11-13 16:01:34
Documents
47
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ogen-10q_20180930.htm 10-Q 931058
2 EX-31.1 ogen-ex311_354.htm EX-31.1 9446
3 EX-31.2 ogen-ex312_353.htm EX-31.2 9237
4 EX-32.1 ogen-ex321_352.htm EX-32.1 5796
5 EX-32.2 ogen-ex322_351.htm EX-32.2 5778
  Complete submission text file 0001564590-18-029292.txt   3754945

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20180930.xml EX-101.INS 536398
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20180930.xsd EX-101.SCH 41295
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20180930_cal.xml EX-101.CAL 24305
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20180930_def.xml EX-101.DEF 184916
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20180930_lab.xml EX-101.LAB 304053
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20180930_pre.xml EX-101.PRE 240159
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 181177846
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1